Aging Brain Center, Hinda and Arthur Marcus Institute for Aging Research, Boston, Massachusetts, USA.
Division of Aging, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
J Am Geriatr Soc. 2020 Aug;68(8):1722-1730. doi: 10.1111/jgs.16420. Epub 2020 Apr 7.
We examined the association between delirium severity and outcomes of delirium among persons with and without Alzheimer's disease and related dementias (ADRD).
Prospective cohort study.
Academic tertiary medical center.
A total of 352 medical and surgical patients.
Delirium incidence and severity were rated daily using the Confusion Assessment Method (CAM) and CAM-Severity (CAM-S) score during hospitalization. Severe delirium was defined as a CAM-S Short Form score in the highest tertile (3-7 points out of 7). ADRD status was determined by a clinical consensus process. Clinical outcomes included prolonged length of stay (>6 d), discharge to post-acute nursing facility, any decline in activities of daily living (ADLs) at 1 month from prehospital baseline, ongoing nursing facility stay, and mortality.
Patients with ADRD (n = 85 [24%]) had a significantly higher relative risk (RR) for incident delirium (RR = 2.31; 95% confidence interval [CI] = 1.64-3.28) and higher peak CAM-S scores (mean difference = 1.24 points; CI = .83-1.65; P < .001). Among patients with ADRD, severe delirium significantly increased the RR for nursing facility stay (RR = 2.22; CI = 1.05-4.69; P = .04) and increased the RR for mortality (RR = 2.10; CI = .89-4.98; P = .09). Among patients without ADRD, severe delirium was associated with a significantly increased risk for all poor outcomes except mortality including prolonged length of stay in the hospital (RR = 1.47; CI = 1.18-1.82) and discharge to a post-acute nursing facility (RR = 2.17; CI = 1.58-2.98) plus decline in ADLs (RR = 1.30; CI = 1.05-1.60) and nursing facility stay at 1 month (RR = 1.93; CI = 1.31-2.83).
Severe delirium is associated with increased risk for poor clinical outcomes in patients with and without ADRD. In both groups, severe delirium increased risk of nursing home placement. In patients with ADRD, delirium was more severe and associated with a trend toward increased mortality at 1 month. Although the increased risk remains substantial by RR, the study had limited power to examine the rarer outcome of death. J Am Geriatr Soc 68:1722-1730, 2020.
我们研究了谵妄严重程度与伴有和不伴有阿尔茨海默病及相关痴呆(ADRD)的患者谵妄结局之间的关系。
前瞻性队列研究。
学术三级医疗中心。
共有 352 名接受内科和外科治疗的患者。
在住院期间,使用意识模糊评估方法(CAM)和 CAM 严重程度(CAM-S)评分,每天评估谵妄的发生率和严重程度。严重谵妄定义为 CAM-S 简易型评分最高三分位数(7 分中 3-7 分)。ADRD 状态通过临床共识过程确定。临床结局包括住院时间延长(>6 天)、出院到急性后护理机构、从入院前基线到 1 个月时日常生活活动(ADL)的任何下降、持续护理机构入住和死亡。
患有 ADRD(n=85 [24%])的患者发生谵妄的相对风险(RR)显著更高(RR=2.31;95%置信区间[CI]为 1.64-3.28),且最高 CAM-S 评分也更高(平均差值=1.24 分;CI=0.83-1.65;P<0.001)。在患有 ADRD 的患者中,严重谵妄显著增加了护理机构入住的 RR(RR=2.22;CI=1.05-4.69;P=0.04),并增加了死亡率的 RR(RR=2.10;CI=0.89-4.98;P=0.09)。在没有 ADRD 的患者中,严重谵妄与除死亡率以外的所有不良结局风险显著增加相关,包括住院时间延长(RR=1.47;CI=1.18-1.82)和出院到急性后护理机构(RR=2.17;CI=1.58-2.98)加上 ADL 下降(RR=1.30;CI=1.05-1.60)和 1 个月时护理机构入住(RR=1.93;CI=1.31-2.83)。
严重谵妄与伴有和不伴有 ADRD 的患者的不良临床结局风险增加相关。在这两组患者中,严重谵妄增加了入住疗养院的风险。在患有 ADRD 的患者中,谵妄更为严重,并与 1 个月时死亡率增加的趋势相关。尽管 RR 显示风险增加幅度较大,但本研究检测死亡率这一罕见结局的效力有限。美国老年医学会杂志 68:1722-1730, 2020。